Lecap Asset Management Ltd. Takes Position in Doximity, Inc. (NASDAQ:DOCS)

Lecap Asset Management Ltd. purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,330 shares of the company’s stock, valued at approximately $625,000.

A number of other large investors have also added to or reduced their stakes in the stock. Fifth Third Bancorp grew its position in Doximity by 181.6% during the second quarter. Fifth Third Bancorp now owns 3,207 shares of the company’s stock worth $90,000 after buying an additional 2,068 shares in the last quarter. First Horizon Advisors Inc. grew its position in Doximity by 80.0% during the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock worth $48,000 after buying an additional 760 shares in the last quarter. Nisa Investment Advisors LLC grew its position in Doximity by 15,714.3% during the second quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company’s stock worth $310,000 after buying an additional 11,000 shares in the last quarter. Blue Trust Inc. grew its position in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after buying an additional 1,193 shares in the last quarter. Finally, SG Americas Securities LLC grew its position in Doximity by 29.6% during the second quarter. SG Americas Securities LLC now owns 16,033 shares of the company’s stock worth $448,000 after buying an additional 3,659 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Anna Bryson sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $30.00, for a total value of $900,000.00. Following the transaction, the chief financial officer now owns 288,685 shares of the company’s stock, valued at approximately $8,660,550. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $28.00, for a total transaction of $70,000.00. Following the transaction, the director now directly owns 10,258 shares of the company’s stock, valued at $287,224. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $30.00, for a total value of $900,000.00. Following the completion of the transaction, the chief financial officer now directly owns 288,685 shares in the company, valued at $8,660,550. The disclosure for this sale can be found here. In the last ninety days, insiders sold 77,951 shares of company stock worth $2,471,018. Company insiders own 39.40% of the company’s stock.

Doximity Trading Up 1.0 %

NASDAQ:DOCS traded up $0.37 during trading hours on Thursday, hitting $36.80. 208,927 shares of the company were exchanged, compared to its average volume of 1,747,535. The stock has a market capitalization of $6.82 billion, a price-to-earnings ratio of 50.31, a price-to-earnings-growth ratio of 5.12 and a beta of 1.22. Doximity, Inc. has a one year low of $19.71 and a one year high of $37.25. The company has a fifty day simple moving average of $29.08 and a 200 day simple moving average of $27.73.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research report on Friday, August 9th. Bank of America upped their target price on Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research note on Friday, August 9th. Canaccord Genuity Group upped their target price on Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday. William Blair restated an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. Finally, Barclays upped their target price on Doximity from $31.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $31.27.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.